INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Pier Capital, LLC's Holding History (CIK: 0001310051)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 65,526 Value ($000) $5,473 Avg Close — Range —
Q3 2024
Shares 65,560 Value ($000) $4,797 Avg Close — Range —
Q2 2024
Shares 64,504 Value ($000) $4,418 Avg Close — Range —
Q1 2024
Shares 54,454 Value ($000) $3,768 Avg Close — Range —
Q4 2023
Shares 55,050 Value ($000) $3,943 Avg Close — Range —
Q3 2023
Shares 149,129 Value ($000) $7,768 Avg Close — Range —
Q2 2023
Shares 150,793 Value ($000) $9,548 Avg Close — Range —
Q1 2023
Shares 147,896 Value ($000) $8,009 Avg Close — Range —
Q4 2022
Shares 142,741 Value ($000) $7,554 Avg Close — Range —
Q3 2022
Shares 144,038 Value ($000) $6,702 Avg Close — Range —
Q2 2022
Shares 116,646 Value ($000) $6,658 Avg Close — Range —
Q4 2020
Shares 190,833 Value ($000) $6,068 Avg Close — Range —
Q2 2015
Shares 257,256 Value ($000) $8,219 Avg Close — Range —